David R. Venturella

Representative Experience

• SERVPRO Recapitalization, Blackstone Partnership
  We represented SERVPRO in its recapitalization transaction, in partnership with Blackstone, one of the world’s leading investment firms. Blackstone is...
  Read More
  Client Type: Private Company
• Engility Holdings Merges with SAIC for $2.5 Billion

  Engility Holdings Merges with SAIC for $2.5 Billion

  We represented Engility Holdings (NYSE: EGL) in its merger with Science Applications International Corp. (NYSE: SAIC) in which SAIC acquired...
  Read More
  Client Type: Public Company
• Quest Diagnostics Acquires Provant Health

  Represented Quest Diagnostics in its acquisition of Provant Health

  We represented Quest Diagnostics (NYSE: DGX) in its acquisition of Provant Health, a health and wellness services provider. Terms of...
  Read More
  Client Type: Public Company
• Quest Diagnostics Acquires ReproSource

  Represented Quest Diagnostics in its acquisition of ReproSource

  We represented Quest Diagnostics (NYSE: DGX) in its acquisition of ReproSource, a Massachusetts-based provider of specialty fertility diagnostic services. Terms...
  Read More
  Client Type: Public Company
• Tennessee Oncology and General Atlantic Create OneOncology
  We represented Tennessee Oncology in the launch of OneOncology in affiliation with global private equity firm General Atlantic. OneOncology is...
  Read More
  Client Type: Private Company
• i3 Verticals, Inc. 2018 Initial Public Offering

  Represented i3 Verticals, Inc. in its initial public offering (IPO) of of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.

  We represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for...
  Read More
  Client Type: Public Company
• i3 Verticals, Inc. 2018 Initial Public Offering

  Represented i3 Verticals, Inc. in its initial public offering (IPO) of of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.

  We represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for...
  Read More
  Client Type: Public Company
• Addus HomeCare Acquires Arcadia Home Care & Staffing

  Represented Addus HomeCare Corporation (Nasdaq: ADUS) in its acquisition of Arcadia Home Care & Staffing.

  We represented Addus HomeCare Corporation (Nasdaq: ADUS) in its acquisition of Arcadia Home Care & Staffing, a Michigan-based provider of...
  Read More
  Client Type: Public Company
• Pharos Capital Launches Verdi Oncology through Horizon Oncology Acquisition

  Represented Pharos Capital Group in its acquisition of Horizon Oncology

  We represented Pharos Capital Group in its acquisition of Horizon Oncology. The acquisition marks the launch of Verdi Oncology, Inc.,...
  Read More
  Client Type: Private Company
• Pharos Capital’s Family Treatment Network Acquires Behavior Care Specialists

  Represented Family Treatment Network in its acquisition of Behavioral Care Specialists

  We represented Family Treatment Network (FTN), a portfolio company of Pharos Capital Group, in its acquisition of Behavioral Care Specialists...
  Read More
  Client Type: Private Company